Enrollment for the randomization phase of SPLASH completed prior to EOY 2022, meeting previous guidance INDIANAPOLIS, Jan. 12, 2023 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback